value focused midd: respiratory syncytial virus (rsv) model-informed drug development program
Published 6 years ago • 821 plays • Length 4:05Download video MP4
Download video MP3
Similar videos
-
3:16
value focused midd: influenza model-informed drug development program
-
3:13
value focused midd: oncology model-informed drug development program
-
43:49
how can model informed drug development impact your program?
-
1:12:39
strategic implementation of model-informed drug development (midd) for regulatory success
-
15:51
model informed drug development approaches for immunogenicity assessments workshop
-
33:21
using model based meta analysis to inform drug development for auto immune diseases
-
4:16
certara's virtual twin: optimizing neurodegenerative disease development with predictive modeling
-
10:28
the methylation cycle simplified | mthfr | methyl groups
-
6:13
cvs case discussion as with ar - md/dnb general medicine
-
28:40
medphys - fluence, fluence rate, energy fluence and energy fluence rate
-
1:57
what you need to know about rsv
-
2:36
introduction to the request study
-
1:00:21
optimize drug development with public data and predictive models – model-based meta-analysis (mbma)
-
1:00
rsv - what is it and who does it affect?
-
0:45
3d structure visualization brachytherapy
-
12:17
gilead: rsv | erik mogalian
-
52:49
using pk/pd m&s for pediatric drug development: regulatory insights into practical issues
-
1:39
what you need to know about rsv
-
1:33
arf6 pathway enhances pd-l1 expression and fibrosis
-
5:35
clinical ddi dataset
-
26:07
clinical applications for the quest with modificatations